Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
+7.83%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$12.1B
AUM Growth
-$653M
(-5.1%)
Cap. Flow
-$1.23B
Cap. Flow
% of AUM
-10.11%
Top 10 Holdings %
Top 10 Hldgs %
16.1%
Holding
578
New
140
Increased
94
Reduced
110
Closed
180
Top Buys
| 1 |
IBM
IBM
|
$272M |
| 2 |
GE Aerospace
GE
|
$149M |
| 3 |
Analog Devices
ADI
|
$143M |
| 4 |
KeyCorp
KEY
|
$131M |
| 5 |
AutoZone
AZO
|
$120M |
Top Sells
| 1 |
Texas Instruments
TXN
|
$213M |
| 2 |
GGP
GGP Inc.
GGP
|
$153M |
| 3 |
General Dynamics
GD
|
$143M |
| 4 |
Zimmer Biomet
ZBH
|
$119M |
| 5 |
Teradata
TDC
|
$106M |
Sector Composition
| 1 | Technology | 18.72% |
| 2 | Industrials | 15.84% |
| 3 | Healthcare | 12.19% |
| 4 | Consumer Discretionary | 11.93% |
| 5 | Financials | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Civitas Resources
CIVI
$3.19B
| $4.44M | 0.04% |
+161,034
| New | +$4.44M |
|
252
Western Alliance Bancorporation
WAL
$10B
| $4.42M | 0.04% |
+78,041
| New | +$4.42M |
|
253
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $4.26M | 0.03% |
484,581
-75,000
| -13% | -$660K |
|
|
NBRV
254
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $4.18M | 0.03% |
2,798
+2
| +0.1% | +$2.99K |
|
255
Ramaco Resources Class A
METC
$1.86B
| $4.13M | 0.03% |
620,154
+51,679
| +9% | +$344K |
|
256
Zevra Therapeutics
ZVRA
$502M
| $4.02M | 0.03% |
62,021
| – | – |
|
257
Brookdale Senior Living
BKD
$1.83B
| $3.96M | 0.03% |
407,684
-166,431
| -29% | -$1.61M |
|
258
Orion
OEC
$596M
| $3.84M | 0.03% |
+150,000
| New | +$3.84M |
|
259
Lincoln Educational Services
LINC
$613M
| $3.71M | 0.03% |
1,836,224
+237,352
| +15% | +$479K |
|
260
KALA BIO
KALA
$102M
| $3.51M | 0.03% |
3,804
+1,256
| +49% | +$1.16M |
|
261
Ascendis Pharma
ASND
$12.5B
| $3.47M | 0.03% |
86,500
-23,500
| -21% | -$941K |
|
|
JNCE
262
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $3.34M | 0.03% |
262,105
| – | – |
|
|
SBNY
263
DELISTED
Signature Bank
SBNY
| $3.33M | 0.03% |
+24,268
| New | +$3.33M |
|
264
Neurogene
NGNE
$285M
| $3.32M | 0.03% |
14,128
| – | – |
|
|
QD
265
Qudian
QD
$733M
| $3.31M | 0.03% |
+263,682
| New | +$3.31M |
|
266
Principal Financial Group
PFG
$17.8B
| $3.24M | 0.03% |
45,958
+14,301
| +45% | +$1.01M |
|
|
AKAO
267
DELISTED
Achaogen, Inc.
AKAO
| $3.22M | 0.03% |
+300,000
| New | +$3.22M |
|
|
BLUE
268
DELISTED
bluebird bio
BLUE
| $3.21M | 0.03% |
+1,390
| New | +$3.21M |
|
|
STRP
269
DELISTED
Straight Path Communications Inc.
STRP
| $3.18M | 0.03% |
17,488
-82,512
| -83% | -$15M |
|
270
Atara Biotherapeutics
ATRA
$90.7M
| $3.17M | 0.03% |
6,995
| – | – |
|
271
Boeing
BA
$174B
| $3.16M | 0.03% |
10,721
-7,170
| -40% | -$2.11M |
|
|
PETQ
272
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $3.15M | 0.03% |
144,034
+46,288
| +47% | +$1.01M |
|
|
CTXS
273
DELISTED
Citrix Systems Inc
CTXS
| $3.05M | 0.02% |
+34,663
| New | +$3.05M |
|
|
MULE
274
DELISTED
MuleSoft, Inc.
MULE
| $3.05M | 0.02% |
+131,118
| New | +$3.05M |
|
|
FSTX
275
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $3.05M | 0.02% |
56,671
-35,297
| -38% | -$1.9M |
|